Related Experiment Video

Updated: Aug 16, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.9K

Does Dexamethasone Helps in Meningococcal Sepsis?

Ilir Tolaj1, Hamdi Ramadani1, Murat Mehmeti1

  • 1Department of Infectious Diseases, University Clinical Centre in Pristina, Kosovo.

Medical Archives (Sarajevo, Bosnia and Herzegovina)
|October 5, 2017
PubMed
Abstract

Insights

Dexamethasone (DXM) shows benefits in treating invasive meningococcal disease (IMD) by shortening hospital stays and aiding white blood cell normalization. This study suggests DXM is a safe adjunctive treatment for IMD, even with limited benefits.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacology
  • Critical Care Medicine

Background:

  • Prompt recognition and aggressive early treatment are crucial for managing invasive meningococcal disease (IMD).
  • The role of anti-inflammatory adjunctive treatments, such as dexamethasone (DXM), in IMD remains debated.
  • Assessing the efficacy of adjunctive therapies in IMD is challenging due to disease complexity.

Purpose of the Study:

  • To evaluate the impact of dexamethasone (DXM) as adjunctive therapy in various clinical presentations of IMD.
  • To determine if DXM should be considered a routine treatment for invasive meningococcal disease.
  • To assess the safety and efficacy of DXM in patients with meningococcal septicaemia and/or meningitis.

Main Methods:

  • A non-interventional clinical study (NIS) included 39 patients with meningococcal septicaemia with or without meningitis.
  • Patients receiving dexamethasone (DXM) were compared to those who did not receive DXM.
  • Statistical analysis was performed using SPSS to compare outcomes.

Main Results:

  • The study included 39 patients, with 76.9% presenting with both sepsis and meningitis.
  • Dexamethasone (DXM) was administered to 61.5% of patients, showing significant statistical differences in length of hospitalization and WBC normalization.
  • The overall mortality rate was 10.3%, with complications including pneumonia (15.4%) and arthritis (7.7%).

Conclusions:

  • Dexamethasone (DXM) demonstrated proven benefits and no harmful effects as an adjunctive therapy in invasive meningococcal disease (IMD).
  • Even limited benefits observed with DXM justify its recommendation as an adjunctive treatment for IMD.
  • The findings support the use of DXM in managing this dangerous infection.
Keywords:
N. meningitidisdexamethasone (DXM)meningitissepsis

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.7K
A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

18.0K

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...